Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chuanjun Shu

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Biochimica Et Biophysica Acta. Molecular Basis of Disease|October 29, 2025
Enhancer hijacking HELLS promotes macrophage M2 polarization results in poor prognosis for prostate cancer patientsLilin Wan, Yue Hou, Dongfang Jiang, et al.
International Journal of Oral Science|March 31, 2025
Macrophage ATF6 accelerates corticotomy-assisted orthodontic tooth movement through promoting Tnfα transcriptionZhichun Jin, Hao Xu, Weiye Zhao, et al.
Theranostics|February 24, 2025
Glucose homeostasis controls N-acetyltransferase 10-mediated ac4C modification of HK2 to drive gastric tumorigenesisQiang Wang, Mengmeng Li, Chen Chen, et al.
Theranostics|July 30, 2020
JP1 suppresses proliferation and metastasis of melanoma through MEK1/2 mediated NEDD4L-SP1-Integrin αvβ3 signalingJiahua Cui, Chuanjun Shu, Jin Xu, et al.
EMBO Reports|June 12, 2023
GAPDH facilitates homologous recombination repair by stabilizing RAD51 in an HDAC1-dependent mannerMunan Shi, Jiajia Hou, Weichu Liang, et al.
Frontiers in Immunology|June 26, 2026
Identification of G4-regulated immune-related drug targets for prostate cancer based on G4 screen and machine learningLiu Ge, Yue Hou, Xuan Huang, et al.
Journal for Immunotherapy of Cancer|April 24, 2023
YY1 complex in M2 macrophage promotes prostate cancer progression by upregulating IL-6Saisai Chen, Kai Lu, Yue Hou, et al.
Theranostics|June 6, 2022
Sequentially targeting and intervening mutual Polo-like Kinase 1 on CAFs and tumor cells by dual targeting nano-platform for cholangiocarcinoma treatmentYue Zhou, Lei Xu, Zhangding Wang, et al.
Cancer Letters|April 17, 2026
PGK1/PHGDH axis drives radioresistance in glioblastoma stem cellsZhangchun Cheng, Fangshu Ding, Jianxing Yin, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|April 22, 2025
MVP-LCN2 axis triggers evasion of ferroptosis to drive hepatocarcinogenesis and sorafenib resistanceJiawen Xu, Bo Wang, Qiaoyu Liu, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Biochimica Et Biophysica Acta. Molecular Basis of Disease|October 29, 2025
Enhancer hijacking HELLS promotes macrophage M2 polarization results in poor prognosis for prostate cancer patientsLilin Wan, Yue Hou, Dongfang Jiang, et al.
International Journal of Oral Science|March 31, 2025
Macrophage ATF6 accelerates corticotomy-assisted orthodontic tooth movement through promoting Tnfα transcriptionZhichun Jin, Hao Xu, Weiye Zhao, et al.
Theranostics|February 24, 2025
Glucose homeostasis controls N-acetyltransferase 10-mediated ac4C modification of HK2 to drive gastric tumorigenesisQiang Wang, Mengmeng Li, Chen Chen, et al.
Theranostics|July 30, 2020
JP1 suppresses proliferation and metastasis of melanoma through MEK1/2 mediated NEDD4L-SP1-Integrin αvβ3 signalingJiahua Cui, Chuanjun Shu, Jin Xu, et al.
EMBO Reports|June 12, 2023
GAPDH facilitates homologous recombination repair by stabilizing RAD51 in an HDAC1-dependent mannerMunan Shi, Jiajia Hou, Weichu Liang, et al.
Frontiers in Immunology|June 26, 2026
Identification of G4-regulated immune-related drug targets for prostate cancer based on G4 screen and machine learningLiu Ge, Yue Hou, Xuan Huang, et al.
Journal for Immunotherapy of Cancer|April 24, 2023
YY1 complex in M2 macrophage promotes prostate cancer progression by upregulating IL-6Saisai Chen, Kai Lu, Yue Hou, et al.
Theranostics|June 6, 2022
Sequentially targeting and intervening mutual Polo-like Kinase 1 on CAFs and tumor cells by dual targeting nano-platform for cholangiocarcinoma treatmentYue Zhou, Lei Xu, Zhangding Wang, et al.
Cancer Letters|April 17, 2026
PGK1/PHGDH axis drives radioresistance in glioblastoma stem cellsZhangchun Cheng, Fangshu Ding, Jianxing Yin, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|April 22, 2025
MVP-LCN2 axis triggers evasion of ferroptosis to drive hepatocarcinogenesis and sorafenib resistanceJiawen Xu, Bo Wang, Qiaoyu Liu, et al.
Pageof 4